Atrioventricular (AV) Valves Summit 2023

Published: 03 November 2023

  • Views:

    Views Icon 3854

  • Likes:

    Heart Icon 7
  • episode_image
    4m 37s
    Part 6 AV Valves Summit at a Glance
    Guillaume Leurent, Marta Sitges, Francesco Maisano, Francesco Bedogni, Lluis Asmarats, Tomás Benito González, Ralph Stephan von Bardeleben
Average (ratings)
No ratings
Your rating

Overview

In this series of short interviews and discussions filmed at AV Valves Summit 2023, the faculty delve into sharing invaluable insights and expert opinion on transcatheter mitral and tricuspid intervention.
They examine a range of topics which include the development of TEER, the importance of quality of life, repair vs replacement and how to best shape the future of MR and TR treatment.

The AV Valves Summit led by course directors Prof Francesco Maisano (San Raffaele Hospital, Milan, IT), Prof Marta Sitges (University of Barcelona, Barcelona, ES), Prof Marco Metra (University of Brescia, Brescia, IT) and Prof Ralph Stephan von Bardeleben (University Medical Center of Mainz, Mainz, DE) provided a platform to advance knowledge and shape the trajectory of this treatment in cardiovascular healthcare.

This programme is supported by an educational grant from Abbott.

Learning Objectives

  • Gain an understanding of the anatomy of mitral and tricuspid valves to inform appropriate intervention strategies
  • The importance of incorporating quality of life considerations into patient management plans, aiming to improve the overall well-being of individuals undergoing valve interventions
  • Learn to identify, prevent, and manage complications associated with mitral and tricuspid valve interventions to ensure patient safety
  • Explore evidence-based strategies for decision-making in heart failure management
  • Assess emerging trends and future innovations impacting the trajectory of mitral and tricuspid valve therapies

Target audience

  • Interventional Cardiologist
  • Echocardiographer
  • Heart Failure Specialist
  • Cardiac Surgeon

More from this programme

Part 1

Course Directors

2 sessions
Summit Overview and Optimising MR and TR Treatments Watch now
Summit Overview: Trending Topics in AV Valves Watch now

Part 2

Mitral and Tricuspid Learnings

1 session
Mitral and Tricuspid Learnings Watch now

Part 3

Exploring Controversies

1 session
Exploring Controversies: Staged, Concomitant and Repair, Replacement Watch now

Part 4

Exploring Transcatheter Edge to Edge Repair

2 sessions
TEER in the UK: Insights into its Origins, Progress and Future Prospects Watch now
TEER vs TAVI: Bridging the Gap in Potential Undertreatment Watch now

Part 5

RMS en France

1 session
Exploration de l'Évolution de la Thérapie de Régurgitation Mitrale Secondaire (RMS) en France Watch now

Part 6

AV Valves Summit at a Glance

1 session
AV Valves Summit at a Glance Watch now

Faculty Biographies

Michael Mullen

Michael Mullen

Consultant interventional cardiologist

Dr Mullen is a consultant cardiologist with the NHS, based at the Barts Heart Centre in London, UK. He is internationally recognised for his expertise in the treatment of structural heart disease, with nearly 20 years of experience in this field. His private practice is based at the Harley Street Clinic and Barts Heart Centre, where he is the clinical lead for structural heart intervention. Previously, he was director of the cardiac catheter laboratories at the Royal Brompton and Harefield NHS Trust.

He has played a key role in the development of new technologies for the treatment of conditions such as valvular heart disease, patent foramen ovale (PFO), atrial septal defect (ASD) and aortic coarctation and their introduction into the UK. These technologies include transcatheter aortic valve implantation (TAVI), MitraClip, Cardioband and suture closure of patent foramen ovale. Dr Mullen has a broad research portfolio, leading and participating in numerous clinical trials…

View full profile